Cardiovascular Risk Reduction in Patients With Chronic Kidney Disease Potential for Targeting Inflammation With Canakinumab

被引：12
|
作者：
Cherney, David Z. I. [1 ,2 ]
Lytvyn, Yuliya [1 ,2 ]
McCullough, Peter A. [3 ]
机构：
[1] Toronto Gen Hosp, Div Nephrol, Dept Med, Toronto, ON, Canada
[2] Univ Toronto, Dept Physiol, Toronto, ON, Canada
[3] Baylor Univ, Med Ctr, Baylor Heart & Vasc Hosp, Dallas, TX USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 21期
关键词：
canakinumab; cardiovascular risk; CKD; inflammation; C-REACTIVE PROTEIN; INTERLEUKIN-1-BETA INHIBITION;
D O I：
10.1016/j.jacc.2018.04.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2415 / 2418
页数：4
相关论文
共 50 条
  • [41] Markers of increased cardiovascular risk in patients with chronic kidney disease
    Gluba-Brzozka, Anna
    Michalska-Kasiczak, Marta
    Franck-Skora, Beata
    Nocun, Marek
    Banach, Maciej
    Rysz, Jacek
    LIPIDS IN HEALTH AND DISEASE, 2014, 13
  • [42] EPIDEMIOLOGY OF CARDIOVASCULAR RISK IN CHINESE CHRONIC KIDNEY DISEASE PATIENTS
    Hou, Fan Fan
    Ma, Zhi Gang
    NEPHROLOGY, 2005, 10 : A151 - A152
  • [43] Therapeutics targeting persistent inflammation in chronic kidney disease
    Machowska, Anna
    Carrero, Juan Jesus
    Lindholm, Bengt
    Stenvinkel, Peter
    TRANSLATIONAL RESEARCH, 2016, 167 (01) : 204 - 213
  • [44] Dyslipidemia in Chronic Kidney Disease: Are Statins Still Indicated in Reduction Cardiovascular Risk in Patients on Dialysis Treatment?
    Scarpioni, Roberto
    Ricardi, Marco
    Melfa, Luigi
    Cristinelli, Luciano
    CARDIOVASCULAR THERAPEUTICS, 2010, 28 (06) : 361 - 368
  • [45] Statins and cardiovascular risk reduction in patients with chronic kidney disease and end-stage renal failure
    Baber, Usman
    Toto, Robert D.
    de Lemos, James A.
    AMERICAN HEART JOURNAL, 2007, 153 (04) : 471 - 477
  • [46] Inflammation, Lymphatics, and Cardiovascular Disease: Amplification by Chronic Kidney Disease
    Kon, Valentina
    Shelton, Elaine L.
    Pitzer, Ashley
    Yang, Hai-Chun
    Kirabo, Annet
    CURRENT HYPERTENSION REPORTS, 2022, 24 (10) : 455 - 463
  • [47] Inflammation, Lymphatics, and Cardiovascular Disease: Amplification by Chronic Kidney Disease
    Valentina Kon
    Elaine L. Shelton
    Ashley Pitzer
    Hai-Chun Yang
    Annet Kirabo
    Current Hypertension Reports, 2022, 24 : 455 - 463
  • [48] INFLAMMATION IS A PREDICTOR OF MORTALITY AND CARDIOVASCULAR EVENTS IN ADVANCED CHRONIC KIDNEY DISEASE PATIENTS
    Liao Ching Hui
    Lin Hugo You-Hsien
    Kuo I-Ching
    Niu Sheng-Wen
    Hwang Shang-Jyh
    Chen Hung-Chun
    Hung Chi-Chih
    NEPHROLOGY, 2014, 19 : 129 - 129
  • [49] The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease
    Rysz, Jacek
    Gluba-Brzozka, Anna
    Rysz-Gorzynska, Magdalena
    Franczyk, Beata
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (02)
  • [50] Haptoglobin Genotype and Risk Markers of Cardiovascular Disease in Patients with Chronic Kidney Disease
    Strandhave, Charlotte
    Svensson, My
    Krarup, Henrik
    Christensen, Jeppe Hagstrup
    INTERNATIONAL JOURNAL OF NEPHROLOGY, 2013, 2013
12345